| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 1st February 2021 | Dane Andreeff | 5,700 | Grant/award etc. | $14.81 | $84,417.00 |
| 1st February 2021 | Dane Andreeff | 2,900 | Grant/award etc. | $14.81 | $42,949.00 |
| 1st February 2021 | Dane Andreeff | 1,800 | Grant/award etc. | $14.81 | $26,658.00 |
| 1st February 2021 | Dane Andreeff | 6,468 | Grant/award etc. | $14.81 | $95,791.08 |
| 21st October 2020 | Dane Andreeff | 371,883 | Grant/award etc. | $0.46 | $171,772.76 |
| 21st October 2020 | Joyce N La Viscount | 38,138 | Grant/award etc. | $0.46 | $17,615.94 |
| 21st October 2020 | Dane Andreeff | 37,363 | Grant/award etc. | $0.46 | $17,257.97 |
| 21st October 2020 | Dane Andreeff | 638,182 | Grant/award etc. | $0.46 | $294,776.27 |
| 21st October 2020 | Dane Andreeff | 134,873 | Grant/award etc. | $0.46 | $62,297.84 |
| 31st July 2020 | Joyce N La Viscount | 4,946 | Grant/award etc. | $0.56 | $2,745.03 |
Helius Medical Technologies
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Helius Medical Technologies, Inc. focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself. The company was founded in 2014 and is headquartered in Newtown, PA.
Ticker: HSDT
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1610853
Employees: 19
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
